Literature DB >> 16211463

Development of microscopic polyangiitis in patients with chronic airway disease.

K Takahashi1, S Hayashi, O Ushiyama, N Sueoka, M Fukuoka, K Nagasawa.   

Abstract

Microscopic polyangiitis (MPA) is a rare systemic vasculitis syndrome, which is often accompanied by positive myeloperoxidase-specific antineutrophil cytoplasmic antibody (MPO-ANCA). While pulmonary involvement of MPA consists mainly of diffuse alveolar hemorrhage and interstitial pneumonia, bronchiectasis has been reported as a pulmonary lesion in association with MPA. To investigate the clinical features of patients with MPA, focusing on the presence or the absence of preceding chronic airway diseases (CAD), we conducted a retrospective observational study of 26 patients in the last 13 years at Saga University Hospital. The clinical records and radiologic chest examinations were reviewed retrospectively. Pulmonary manifestations were alveolar hemorrhage in 3 patients (12%) and interstitial pneumonia in 5 (19%). Bronchiectasis, defined by the findings of chest radiograph and computed tomography, was found in 9 patients (35%). Four patients (15%) with bronchiectasis and one patient (4%) with chronic bronchitis had experienced chronic bronchial suppuration prior to the onset of MPA. Ten patients were classified as having chronic airway disease (CAD) before the onset of MPA. MPO-ANCA tended to be lower in the CAD group than in the non-CAD group. None of the patients in the CAD group had pulmonary hemorrhage or interstitial pneumonia. Only one patient (10%) in the CAD group died within 90 days of the onset of MPA, while 7 (43.8%) of the non-CAD group died. Our study suggests that MPA may result in part from CAD and that the clinical course of MPA with CAD may be different from MPA without CAD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16211463     DOI: 10.1007/s00408-004-2540-1

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  10 in total

1.  Systemic hypersensitivity vasculitis associated with bronchiectasis.

Authors:  E Tanaka; K Tada; R Amitani; F Kuze
Journal:  Chest       Date:  1992-08       Impact factor: 9.410

2.  Chronic bronchial suppuration and antineutrophil cytoplasmic antibody (ANCA) positive systemic vasculitis.

Authors:  D Sitara; B I Hoffbrand
Journal:  Postgrad Med J       Date:  1990-08       Impact factor: 2.401

3.  Microscopic polyangiitis associated with sinobronchial syndrome.

Authors:  T Nagata; K Hara; T Oka; Y Yamaguchi; K Igarashi; H Hazama; M Omata
Journal:  Intern Med       Date:  2001-06       Impact factor: 1.271

4.  Immunological abnormalities in bronchiectasis with chronic bronchial suppuration.

Authors:  A M Hilton; L Doyle
Journal:  Br J Dis Chest       Date:  1978-07

5.  Cutaneous vasculitis and immune complexes in severe bronchiectasis.

Authors:  A M Hilton; P S Hasleton; A Bradlow; B C Leahy; K M Cooper; M Moore
Journal:  Thorax       Date:  1984-03       Impact factor: 9.139

Review 6.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

Authors:  J C Jennette; R J Falk; K Andrassy; P A Bacon; J Churg; W L Gross; E C Hagen; G S Hoffman; G G Hunder; C G Kallenberg
Journal:  Arthritis Rheum       Date:  1994-02

7.  Antineutrophil cytoplasmic antibodies in diffuse panbronchiolitis.

Authors:  Y Sugiyama; S Kitamura
Journal:  Respiration       Date:  1999       Impact factor: 3.580

8.  Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice.

Authors:  Hong Xiao; Peter Heeringa; Peiqi Hu; Zhi Liu; Minglang Zhao; Yasuaki Aratani; Nobuyo Maeda; Ronald J Falk; J Charles Jennette
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

9.  Bronchiectasis with myeloperoxidase antineutrophil cytoplasmic antibody and bactericidal/permeability-increasing protein antineutrophil cytoplasmic antibody.

Authors:  W Matsuyama; J Wakimoto; A Watanabe; I Kubota; Y Hirotsu; A Mizoguchi; F Iwami; M Kawabata; M Osame
Journal:  Intern Med       Date:  1999-10       Impact factor: 1.271

10.  Immunological abnormalities in patients with chronic bronchial suppuration: a possible relationship with endotoxaemia.

Authors:  M A Horan; B C Leahy; R A Fox; T B Stretton; M Haeney
Journal:  Br J Dis Chest       Date:  1984-01
  10 in total
  3 in total

1.  Characteristics and prognosis of microscopic polyangiitis with bronchiectasis.

Authors:  Hiroki Tashiro; Koichiro Takahashi; Masahide Tanaka; Kazutoshi Komiya; Tomomi Nakamura; Shinya Kimura; Yoshifumi Tada; Naoko Sueoka-Aragane
Journal:  J Thorac Dis       Date:  2017-02       Impact factor: 2.895

Review 2.  Interstital lung disease in ANCA vasculitis.

Authors:  Marco A Alba; Luis Felipe Flores-Suárez; Ashley G Henderson; Hong Xiao; Peiqi Hu; Patrick H Nachman; Ronald J Falk; J Charles Jennette
Journal:  Autoimmun Rev       Date:  2017-05-04       Impact factor: 9.754

3.  Novel insights into the aetiology of granulomatosis with polyangiitis-a case-control study using the Clinical Practice Research Datalink.

Authors:  Fiona A Pearce; Peter C Lanyon; Richard A Watts; Matthew J Grainge; Abhishek Abhishek; Richard B Hubbard
Journal:  Rheumatology (Oxford)       Date:  2018-06-01       Impact factor: 7.580

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.